OKUR vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

OKUR
OnKure Therapeutics, Inc.
SELL
75%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

OKUR vs MSFT Fundamental Comparison

Metric OKUR MSFT
Revenue $3.4M $158.9B
Net Income $-59.5M $66.2B
Net Margin -1,733.7% 41.7%
ROE -105.9% 16.9%
ROA -95.8% 10.0%
Current Ratio 10.28x 1.39x
Debt/Equity 0.00x 0.10x
EPS $-4.40 $8.87

Green = Better metric | Red = Weaker metric

View Full OKUR Analysis →
View Full MSFT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OKUR vs AAPL MSFT vs GOOGL OKUR vs AMZN MSFT vs NVDA

OKUR vs MSFT: Frequently Asked Questions

Is OKUR or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. OKUR is rated SELL (75% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does OKUR compare to MSFT fundamentally?

OnKure Therapeutics, Inc. has ROE of -105.9% vs MICROSOFT CORP's 16.9%. Net margins are -1,733.7% vs 41.7% respectively.

Which stock pays higher dividends, OKUR or MSFT?

OKUR has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OKUR or MSFT for long term?

For long-term investing, consider that OKUR has SELL rating with 75% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OKUR vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OKUR vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.